IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.130
-0.030 (-1.39%)
Oct 15, 2025, 4:00 PM EDT - Market closed
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.67 million as of October 16, 2025. Its market cap has decreased by -27.69% in one year.
Market Cap
9.67M
Enterprise Value
-438.40K
1-Year Change
-27.69%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.67M, a decrease of -94.84%. That is a compound annual growth rate of -50.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 9.81M | -47.40% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.75B |
| Johnson & Johnson | 453.61B |
| AbbVie | 404.06B |
| UnitedHealth Group | 326.61B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.13B |
| Abbott Laboratories | 230.04B |